Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | -6.37% | -14.16% | -14.16% |
Business Summary
Number of employees: 130
Managers
Managers | Title | Age | Since |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 19-12-31 |
Chief Operating Officer | - | 21-02-28 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 21-05-31 |
Sharon Townson
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-06-30 |
Owen Wallace
CTO | Chief Tech/Sci/R&D Officer | 55 | 21-01-31 |
John Castle
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-04-30 |
Philip Nickson
LAW | General Counsel | 45 | 21-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
CHM | Chairman | 58 | 20-08-31 |
Christine Siu
BRD | Director/Board Member | 47 | 20-11-30 |
Chandra Paul Leo
BRD | Director/Board Member | 53 | 20-08-31 |
Ali Behbahani
BRD | Director/Board Member | 47 | 20-03-31 |
Anthony Manning
BRD | Director/Board Member | 62 | 23-07-24 |
Markus Warmuth
CEO | Chief Executive Officer | 53 | 19-12-31 |
Jan Skvarka
BRD | Director/Board Member | 57 | 23-03-22 |
Director/Board Member | 55 | 20-05-31 | |
Alexander Mayweg
BRD | Director/Board Member | 49 | 18-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,522,024 | 49,892,025 ( 98.75 %) | 10,005 ( 0.0198 %) | 98.75 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.16% | 245M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- GLUE Stock
- Company Monte Rosa Therapeutics, Inc.